Market Cap 6.80B
Revenue (ttm) 158.32M
Net Income (ttm) -68.92M
EPS (ttm) N/A
PE Ratio 508.64
Forward PE 23.58
Profit Margin -43.53%
Debt to Equity Ratio 1.64
Volume 797,860
Avg Vol 2,116,656
Day's Range N/A - N/A
Shares Out 88.93M
Stochastic %K 61%
Beta 0.55
Analysts Strong Sell
Price Target $74.25

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
KeelinTime
KeelinTime Jul. 16 at 12:03 PM
0 · Reply
Ceherring
Ceherring Jul. 15 at 6:41 PM
0 · Reply
KeelinTime
KeelinTime Jul. 15 at 10:28 AM
0 · Reply
WAJeff
WAJeff Jul. 14 at 2:40 PM
$LQDA Quick 72.01 to 74 flip since yesterday. This has been a quiet monster. I used to trade this in the low teens in early 2024.
0 · Reply
Ceherring
Ceherring Jul. 14 at 2:20 PM
0 · Reply
KeelinTime
KeelinTime Jul. 14 at 9:51 AM
0 · Reply
msgu1021
msgu1021 Jul. 13 at 6:54 PM
$LQDA Heavy beating today! Any reason?
3 · Reply
JFais
JFais Jul. 13 at 3:38 PM
Have plenty of positions with outsized gain (ie. $LQDA and $SNDX among others) Just a matter of taking partial profits to rotate $$ into setups currently getting beat up vs holding patiently for continued upside When in doubt, no rush to trade (FOMO's a key weakness of mine)
0 · Reply
KeelinTime
KeelinTime Jul. 13 at 10:09 AM
0 · Reply
SteelerJon
SteelerJon Jul. 12 at 8:33 PM
$LQDA 😎🏦🏦
0 · Reply
Latest News on LQDA
Liquidia downgraded to Neutral from Buy at BofA

2026-06-29T10:30:39.000Z - 17 days ago

Liquidia downgraded to Neutral from Buy at BofA


Liquidia price target raised to $109 from $59 at BTIG

2026-06-22T11:32:52.000Z - 24 days ago

Liquidia price target raised to $109 from $59 at BTIG


Liquidia Transcript: AGM 2026

Jun 16, 2026, 4:30 PM EDT - 4 weeks ago

Liquidia Transcript: AGM 2026


Liquidia announces inclusion in S&P SmallCap 600 Index

2026-06-08T13:08:28.000Z - 5 weeks ago

Liquidia announces inclusion in S&P SmallCap 600 Index


Liquidia rises 17.6%

2026-06-04T16:09:07.000Z - 6 weeks ago

Liquidia rises 17.6%


Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T18:47:33.000Z - 2 months ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright


Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-12T11:38:21.000Z - 2 months ago

Liquidia price target raised to $62 from $51 at Wells Fargo


Liquidia price target raised to $60 from $57 at Jefferies

2026-05-11T21:57:52.000Z - 2 months ago

Liquidia price target raised to $60 from $57 at Jefferies


Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Earnings Call Transcript: Q1 2026


Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Earnings release: Q1 2026


Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Quarterly report: Q1 2026


Liquidia Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 2 months ago

Liquidia Slides: Q1 2026


Liquidia reports Q1 EPS 52c, consensus 41c

2026-05-11T11:28:55.000Z - 2 months ago

Liquidia reports Q1 EPS 52c, consensus 41c


Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing


Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing


Liquidia price target raised to $51 from $44 at Wells Fargo

2026-03-23T10:32:21.000Z - 4 months ago

Liquidia price target raised to $51 from $44 at Wells Fargo

INSM


Liquidia price target raised to $19 from $16 at Oppenheimer

2026-03-12T11:52:04.000Z - 4 months ago

Liquidia price target raised to $19 from $16 at Oppenheimer


Liquidia rises 7.7%

2026-03-06T15:06:42.000Z - 4 months ago

Liquidia rises 7.7%


Liquidia price target raised to $55 from $50 at H.C. Wainwright

2026-03-06T11:16:01.000Z - 4 months ago

Liquidia price target raised to $55 from $50 at H.C. Wainwright


Liquidia files automatic mixed securities shelf

2026-03-05T21:46:18.000Z - 4 months ago

Liquidia files automatic mixed securities shelf


Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Earnings Call Transcript: Q4 2025


Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Annual report: Q4 2025


Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Earnings release: Q4 2025


Liquidia Slides: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Liquidia Slides: Q4 2025


Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 6 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference


Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 8:00 AM EST - 8 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025


Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 8 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025


Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Earnings Call Transcript: Q3 2025


Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Quarterly report: Q3 2025


Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Earnings release: Q3 2025


Liquidia Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Slides: Q3 2025


Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 9 months ago

Liquidia Transcript: R&D Day 2025


Liquidia Slides: FY 2025

Oct 28, 2025, 3:00 PM EDT - 9 months ago

Liquidia Slides: FY 2025


Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2025


Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q2 2025


Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q2 2025


Liquidia Slides: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Q2 2025


Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update


Liquidia Slides: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update


Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025


Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025


Liquidia Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025


Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing


Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing


Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024


Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024


Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024


Liquidia Registration statement: Registration Filing

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing


Liquidia Slides: FY 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025


Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference


Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024


Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024


Liquidia Earnings release: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024


KeelinTime
KeelinTime Jul. 16 at 12:03 PM
0 · Reply
Ceherring
Ceherring Jul. 15 at 6:41 PM
0 · Reply
KeelinTime
KeelinTime Jul. 15 at 10:28 AM
0 · Reply
WAJeff
WAJeff Jul. 14 at 2:40 PM
$LQDA Quick 72.01 to 74 flip since yesterday. This has been a quiet monster. I used to trade this in the low teens in early 2024.
0 · Reply
Ceherring
Ceherring Jul. 14 at 2:20 PM
0 · Reply
KeelinTime
KeelinTime Jul. 14 at 9:51 AM
0 · Reply
msgu1021
msgu1021 Jul. 13 at 6:54 PM
$LQDA Heavy beating today! Any reason?
3 · Reply
JFais
JFais Jul. 13 at 3:38 PM
Have plenty of positions with outsized gain (ie. $LQDA and $SNDX among others) Just a matter of taking partial profits to rotate $$ into setups currently getting beat up vs holding patiently for continued upside When in doubt, no rush to trade (FOMO's a key weakness of mine)
0 · Reply
KeelinTime
KeelinTime Jul. 13 at 10:09 AM
0 · Reply
SteelerJon
SteelerJon Jul. 12 at 8:33 PM
$LQDA 😎🏦🏦
0 · Reply
Ceherring
Ceherring Jul. 12 at 1:03 PM
0 · Reply
KeelinTime
KeelinTime Jul. 12 at 10:14 AM
0 · Reply
buyonthego
buyonthego Jul. 11 at 8:47 PM
$LQDA I like your thinking. They will be on a 1 billion run rate in revenue come the end of Q4, 250 million in Q4. This is easily a 2 billion in revenue run rate company come end of 2027. Cheers, shareholder since 2018. 🍺
0 · Reply
BullRun4
BullRun4 Jul. 11 at 2:57 PM
$LQDA A profitable Liquidia isn't just an acquisition target — it's a company that could choose to stay independent. That bargaining power means any bid needs a meaningful premium (40%+) to get a deal done. Most Likely Outcome $10–11 billion total deal value (~$112$124/share) This represents: • A 10–11x revenue multiple on ~$1B in profitable revenue • A 40–60% premium to the current ~$78 price • Alignment with the analyst high target of $109 (which may be conservative now) • The Merck/Verona precedent adjusted for revenue de-risking and profitability Bottom Line: Profitability shifts Liquidia from a "hope and revenue" story to a "proven business with growth" story. At ~$1B in revenue with earnings, $10B+ is not just realistic — it's arguably the floor. Anything below ~$100/share (~$9B) would likely be rejected by shareholders who can see the standalone value. In a few more years it’s value should go up to $15+ billion!!!
3 · Reply
msgu1021
msgu1021 Jul. 10 at 5:56 PM
$LQDA for a change LQDA is down and $MNKD is up ..how about that ?
2 · Reply
SteelerJon
SteelerJon Jul. 10 at 3:22 PM
$LQDA 😎🏦🏦
0 · Reply
msgu1021
msgu1021 Jul. 10 at 2:51 PM
$LQDA any breakout news?
0 · Reply
kshonstocks
kshonstocks Jul. 10 at 1:14 PM
https://research.investors.com/stock-lists/relative-strength-at-new-high/# $BAND $LQDA 1 and 2
0 · Reply
Ceherring
Ceherring Jul. 10 at 12:59 PM
0 · Reply
KeelinTime
KeelinTime Jul. 10 at 10:14 AM
0 · Reply
buyonthego
buyonthego Jul. 9 at 9:40 PM
$LQDA $MNKD I enjoy my little chuckle when post, thank you. 🤓 One month till earnings, can’t wait. 🍺
0 · Reply
JustAnotherAffizle
JustAnotherAffizle Jul. 9 at 8:45 PM
$LQDA continues to kick ass and take names while $MNKD continues to be the 💩 stain on stevemano's panties! LOLZ!
0 · Reply